Your browser doesn't support javascript.
loading
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Swisher, Elizabeth M; Lin, Kevin K; Oza, Amit M; Scott, Clare L; Giordano, Heidi; Sun, James; Konecny, Gottfried E; Coleman, Robert L; Tinker, Anna V; O'Malley, David M; Kristeleit, Rebecca S; Ma, Ling; Bell-McGuinn, Katherine M; Brenton, James D; Cragun, Janiel M; Oaknin, Ana; Ray-Coquard, Isabelle; Harrell, Maria I; Mann, Elaina; Kaufmann, Scott H; Floquet, Anne; Leary, Alexandra; Harding, Thomas C; Goble, Sandra; Maloney, Lara; Isaacson, Jeff; Allen, Andrew R; Rolfe, Lindsey; Yelensky, Roman; Raponi, Mitch; McNeish, Iain A.
Affiliation
  • Swisher EM; University of Washington, Seattle, WA, USA. Electronic address: swishere@uw.edu.
  • Lin KK; Clovis Oncology, Boulder, CO, USA.
  • Oza AM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Scott CL; Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Giordano H; Clovis Oncology, Boulder, CO, USA.
  • Sun J; Foundation Medicine, Cambridge, MA, USA.
  • Konecny GE; University of California Los Angeles, Santa Monica, CA, USA.
  • Coleman RL; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tinker AV; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • O'Malley DM; The Ohio State University, James Cancer Center, Columbus, OH, USA.
  • Kristeleit RS; University College London, Cancer Institute, London, UK.
  • Ma L; Rocky Mountain Cancer Centers, Lakewood, CO, USA.
  • Bell-McGuinn KM; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Cragun JM; The University of Arizona Cancer Center, Tucson, AZ, USA.
  • Oaknin A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Ray-Coquard I; GINECO, Centre Léon Bérard and University Claude Bernard, Lyon, France.
  • Harrell MI; University of Washington, Seattle, WA, USA.
  • Mann E; Clovis Oncology, Boulder, CO, USA.
  • Kaufmann SH; Mayo Clinic, Rochester, MN, USA.
  • Floquet A; Institut Bergonié, Bordeaux, France.
  • Leary A; Gustave Roussy Cancer Center and INSERM U981, Villejuif, France.
  • Harding TC; Clovis Oncology, Boulder, CO, USA.
  • Goble S; Clovis Oncology, Boulder, CO, USA.
  • Maloney L; Clovis Oncology, Boulder, CO, USA.
  • Isaacson J; Clovis Oncology, Boulder, CO, USA.
  • Allen AR; Clovis Oncology, Boulder, CO, USA.
  • Rolfe L; Clovis Oncology, Boulder, CO, USA.
  • Yelensky R; Foundation Medicine, Cambridge, MA, USA.
  • Raponi M; Clovis Oncology, Boulder, CO, USA.
  • McNeish IA; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Lancet Oncol ; 18(1): 75-87, 2017 01.
Article in En | MEDLINE | ID: mdl-27908594

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Platinum / Neoplasms, Glandular and Epithelial / Drug Resistance, Neoplasm / Fallopian Tube Neoplasms / Indoles / Neoplasm Recurrence, Local Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Platinum / Neoplasms, Glandular and Epithelial / Drug Resistance, Neoplasm / Fallopian Tube Neoplasms / Indoles / Neoplasm Recurrence, Local Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: